Quote For Celgene Corporation CELG.O
Celgene Corporation (CELG.O) (Nasdaq)
sector: Healthcare ·
industry: Biotechnology ·
$54.97
27 Nov 2009
-1.40%
$54.97
--
1,325,760
$55.68
$53.72
$58.31
$36.90
0.50
2,667,873
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Barer, Sol | Chairman of the Board, Chief Executive Officer | 8,525,090 |
| Hugin, Robert | President, Chief Operating Officer, Director | 5,158,400 |
| Gryska, David | Chief Financial Officer, Senior Vice President | 2,138,500 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $25,264.34 |
| Shares Outstanding (Mil.) | 459.60 |
| Float (Mil.) | 458.20 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 5.20 |
| Current Ratio | 7.13 |
| LT Debt/Equity | 0.00 |
| Total Debt/Equity | 0.00 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 69.69 |
| Price/Sales(TTM) | 9.88 |
| Price/Book(TTM) | 6.14 |
| Price/Cash Flow(TTM) | 48.96 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $0.81 |
| Sales(TTM) | $5.51 |
| Book Value(MRQ) | $8.95 |
| Cash Flow(TTM) | $1.11 |
| Cash(MRQ) | $6.02 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 9.70 |
| Return on Assets(TTM) | 7.91 |
| Return on Investment(TTM) | 8.78 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 90.81 |
| Operating Margin(TTM) % | 16.60 |
| Profit Margin(TTM) % | 14.60 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
